Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by University of Louisville
Sponsor:
Collaborators:
Northwestern University
Regenerex, LLC
Information provided by (Responsible Party):
University of Louisville
ClinicalTrials.gov Identifier:
NCT00497926
First received: July 6, 2007
Last updated: September 26, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2030
  Estimated Primary Completion Date: March 2025 (Final data collection date for primary outcome measure)